AU2004263238A1 - Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof - Google Patents
Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof Download PDFInfo
- Publication number
- AU2004263238A1 AU2004263238A1 AU2004263238A AU2004263238A AU2004263238A1 AU 2004263238 A1 AU2004263238 A1 AU 2004263238A1 AU 2004263238 A AU2004263238 A AU 2004263238A AU 2004263238 A AU2004263238 A AU 2004263238A AU 2004263238 A1 AU2004263238 A1 AU 2004263238A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- aryl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10334040A DE10334040A1 (de) | 2003-07-25 | 2003-07-25 | Neue N-substituierte Indolyl-3-glyoxylsäureamide, deren Verwendung als Arzneimittel und Verfahren zu deren Herstellung |
| DE10334040.8 | 2003-07-25 | ||
| PCT/EP2004/007573 WO2005014542A2 (de) | 2003-07-25 | 2004-07-09 | Neue n-substituierte indolyl-3-glyoxylsäureamide, deren verwendung als arzneimittel gegen krebs und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2004263238A1 true AU2004263238A1 (en) | 2005-02-17 |
Family
ID=34129467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004263238A Abandoned AU2004263238A1 (en) | 2003-07-25 | 2004-07-09 | Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1651600A2 (xx) |
| JP (1) | JP2007503376A (xx) |
| KR (1) | KR20060037398A (xx) |
| CN (1) | CN1839129A (xx) |
| AR (1) | AR045928A1 (xx) |
| AU (1) | AU2004263238A1 (xx) |
| BR (1) | BRPI0412898A (xx) |
| CA (1) | CA2533433A1 (xx) |
| DE (1) | DE10334040A1 (xx) |
| IL (1) | IL173335A0 (xx) |
| MX (1) | MXPA06000995A (xx) |
| NO (1) | NO20060697L (xx) |
| RS (1) | RS20060049A (xx) |
| RU (1) | RU2317293C9 (xx) |
| TW (1) | TW200524863A (xx) |
| UA (1) | UA83498C2 (xx) |
| WO (1) | WO2005014542A2 (xx) |
| ZA (1) | ZA200601300B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5406716B2 (ja) | 2006-08-07 | 2014-02-05 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | インドール化合物 |
| AR084433A1 (es) | 2010-12-22 | 2013-05-15 | Ironwood Pharmaceuticals Inc | Inhibidores de la faah y composiciones farmaceuticas que los contienen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003022280A2 (en) * | 2001-09-13 | 2003-03-20 | Synta Pharmaceuticals Corp. | 3-glyoxlylamideindoles for treating cancer |
-
2003
- 2003-07-25 DE DE10334040A patent/DE10334040A1/de not_active Withdrawn
-
2004
- 2004-07-09 AU AU2004263238A patent/AU2004263238A1/en not_active Abandoned
- 2004-07-09 RU RU2006105708/04A patent/RU2317293C9/ru not_active IP Right Cessation
- 2004-07-09 MX MXPA06000995A patent/MXPA06000995A/es unknown
- 2004-07-09 EP EP04740854A patent/EP1651600A2/de not_active Withdrawn
- 2004-07-09 WO PCT/EP2004/007573 patent/WO2005014542A2/de active Application Filing
- 2004-07-09 BR BRPI0412898-2A patent/BRPI0412898A/pt not_active IP Right Cessation
- 2004-07-09 RS YUP-2006/0049A patent/RS20060049A/sr unknown
- 2004-07-09 JP JP2006521430A patent/JP2007503376A/ja not_active Withdrawn
- 2004-07-09 CN CNA2004800240832A patent/CN1839129A/zh active Pending
- 2004-07-09 KR KR1020067001636A patent/KR20060037398A/ko not_active Application Discontinuation
- 2004-07-09 CA CA002533433A patent/CA2533433A1/en not_active Abandoned
- 2004-07-19 TW TW093121509A patent/TW200524863A/zh unknown
- 2004-07-23 AR ARP040102632A patent/AR045928A1/es not_active Application Discontinuation
- 2004-09-07 UA UAA200601216A patent/UA83498C2/uk unknown
-
2006
- 2006-01-24 IL IL173335A patent/IL173335A0/en unknown
- 2006-02-13 ZA ZA200601300A patent/ZA200601300B/xx unknown
- 2006-02-14 NO NO20060697A patent/NO20060697L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL173335A0 (en) | 2006-06-11 |
| ZA200601300B (en) | 2007-03-28 |
| EP1651600A2 (de) | 2006-05-03 |
| RU2317293C2 (ru) | 2008-02-20 |
| DE10334040A1 (de) | 2005-03-10 |
| RU2006105708A (ru) | 2006-06-27 |
| JP2007503376A (ja) | 2007-02-22 |
| RU2317293C9 (ru) | 2008-05-10 |
| NO20060697L (no) | 2006-02-14 |
| RS20060049A (xx) | 2008-08-07 |
| TW200524863A (en) | 2005-08-01 |
| WO2005014542A3 (de) | 2006-10-19 |
| CN1839129A (zh) | 2006-09-27 |
| KR20060037398A (ko) | 2006-05-03 |
| BRPI0412898A (pt) | 2006-10-03 |
| MXPA06000995A (es) | 2006-04-11 |
| WO2005014542A2 (de) | 2005-02-17 |
| UA83498C2 (uk) | 2008-07-25 |
| AR045928A1 (es) | 2005-11-16 |
| CA2533433A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114269735B (zh) | 二氢或四氢喹唑啉类化合物及其中间体、制备方法和应用 | |
| CN108383836B (zh) | 作为mek抑制剂的杂环基化合物 | |
| CA2524525C (en) | Novel pyridopyrazines and use thereof as kinase modulators | |
| KR20050072824A (ko) | 과다증식성 질환 및 혈관신생과 관련된 질병의 치료에유용한 인돌릴 피라지논 유도체 | |
| AU2004268948A1 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
| JP2007502822A (ja) | ｃ−Ｋｉｔ阻害剤としてのＮ３−置換イミダゾピリジン誘導体 | |
| WO2015077193A1 (en) | Inhibitors of lysine methyl transferase | |
| AU2004240746A1 (en) | Novel pyridopyrazines and use thereof as kinase inhibitors | |
| AU2003246571B2 (en) | Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases | |
| ES2450067T3 (es) | Derivados de pirido[2,3-d]pirimidina, proceso para su preparación y su uso terapéutico | |
| CN110229171B (zh) | 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用 | |
| MX2011010329A (es) | Derivados de quinoxalina y su uso para el tratamiento de trastornos de tumores benignos y malignos. | |
| US7211588B2 (en) | N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation | |
| US20050009809A1 (en) | Acridine derivatives and their use as medicaments | |
| EP4242207A1 (en) | Kras inhibitors for treatment of cancers | |
| AU2004263238A1 (en) | Novel N-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof | |
| CN114728910B (zh) | 用于fgfr抑制剂的吡唑类衍生物及其制备方法 | |
| CN115894520A (zh) | 一种大环k-ras g12c抑制剂及其制备方法和在药学上的应用 | |
| CN110229172B (zh) | 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用 | |
| CN111875583A (zh) | 三氮唑衍生物及其制备方法和用途 | |
| WO2011078226A1 (ja) | 三環系化合物 | |
| CN111868060B (zh) | 二氢吡啶并酞嗪酮衍生物、其制备方法及应用 | |
| CN116529252A (zh) | 用于持续释放治疗剂的前药及其用途 | |
| CN112441980A (zh) | 用于fgfr抑制剂的吡唑类衍生物及其制备方法 | |
| CN114555597A (zh) | 异柠檬酸脱氢酶（idh）抑制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |